164 related articles for article (PubMed ID: 120622)
1. Heroin addiction: relationship between the plasma levels of testosterone, dihydrotestosterone, androstenedione, LH, FSH, and the plasma concentration of heroin.
Bolelli G; Lafisca S; Flamigni C; Lodi S; Franceschetti F; Filicori M; Mosca R
Toxicology; 1979 Dec; 15(1):19-29. PubMed ID: 120622
[TBL] [Abstract][Full Text] [Related]
2. Pituitary-gonadal function in heroin addicts.
Brambilla F; Sacchetti E; Brunetta M
Neuropsychobiology; 1977; 3(2-3):160-6. PubMed ID: 331136
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin response to synthetic gonadotropin hormone-releasing hormone (GnRH) in heroin addicts.
Brambilla F; Resele L; De Maio D; Nobile P
Am J Psychiatry; 1979 Mar; 136(3):314-7. PubMed ID: 369397
[TBL] [Abstract][Full Text] [Related]
4. Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude.
Iliff-Sizemore SA; Ortolano GA; Haisenleder DJ; Dalkin AC; Krueger KA; Marshall JC
Endocrinology; 1990 Dec; 127(6):2876-83. PubMed ID: 1701131
[TBL] [Abstract][Full Text] [Related]
5. Effect of gonadotrophin-releasing hormone analogue (GnRH-A) administration on serum gonadotrophin and steroid levels in patients with polycystic ovarian disease.
Mongioi A; Maugeri G; Macchi M; Calogero A; Vicari E; Coniglione F; Aliffi A; Sipione C; D'Agata R
Acta Endocrinol (Copenh); 1986 Feb; 111(2):228-34. PubMed ID: 3082098
[TBL] [Abstract][Full Text] [Related]
6. Heroin addiction and sex hormones in males.
Malik SA; Khan C; Jabbar A; Iqbal A
J Pak Med Assoc; 1992 Sep; 42(9):210-2. PubMed ID: 1433805
[TBL] [Abstract][Full Text] [Related]
7. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
8. Zinc, prolactin, gonadotropins, and androgen levels in uremic men.
Paniagua R; Arreola F; Herrera J; Pérez A; Díaz S; Mondragón L; Sereno O; Villalpando S; Exaire E; Bermúdez JA
Arch Androl; 1982 Jun; 8(4):271-5. PubMed ID: 6810775
[TBL] [Abstract][Full Text] [Related]
9. [Serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone versus prostate specific antigen in patients with localized prostate adenocarcinoma who underwent radical prostatectomy. Radioimmunoassays measurements].
Bantis A; Zissimopoulos A; Athanasiadou P; Gonidi M; Agelonidou E; Strataki A; Matthaios D; Tsartsarakis A
Hell J Nucl Med; 2007; 10(1):56-61. PubMed ID: 17450256
[TBL] [Abstract][Full Text] [Related]
10. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression.
Weber B; Lewicka S; Deuschle M; Colla M; Heuser I
Psychoneuroendocrinology; 2000 Nov; 25(8):765-71. PubMed ID: 10996472
[TBL] [Abstract][Full Text] [Related]
11. Effect of infusion of gonadotropin releasing hormone upon plasma concentrations of sex hormones in prepubertal and pubertal males.
Reiter EO; Fuldauer VG; Root AW
Steroids; 1976 Dec; 28(6):829-35. PubMed ID: 138215
[TBL] [Abstract][Full Text] [Related]
12. Studies of gonadotropin-gonadal dynamics in patients with androgen insensitivity.
Boyar RM; Moore RJ; Rosner W; Aiman J; Chipman J; Madden JD; Marks JF; Griffin JE
J Clin Endocrinol Metab; 1978 Nov; 47(5):1116-22. PubMed ID: 122420
[TBL] [Abstract][Full Text] [Related]
13. The role of androgen in the development of sexual differences in pituitary responsiveness to gonadotropin releasing hormone (GnRH) agonist in the bullfrog, Rana catesbeiana.
McCreery BR; Licht P
Gen Comp Endocrinol; 1984 Jun; 54(3):350-9. PubMed ID: 6428973
[TBL] [Abstract][Full Text] [Related]
14. Measurement of gonadotrophins, testosterone, delta4 androstenedione and dihydrotesterone in idiopathic oligospermia.
Roulier R; Mattei A; Duvivier J; Franchimont P
Clin Endocrinol (Oxf); 1978 Oct; 9(4):303-11. PubMed ID: 363307
[TBL] [Abstract][Full Text] [Related]
15. Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: relationship with the CD4 cell counts.
Laudat A; Blum L; Guéchot J; Picard O; Cabane J; Imbert JC; Giboudeau J
Eur J Endocrinol; 1995 Oct; 133(4):418-24. PubMed ID: 7581964
[TBL] [Abstract][Full Text] [Related]
16. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
17. Hormone levels in methadone-treated drug addicts.
Lafisca S; Bolelli G; Franceschetti F; Filicori M; Flamigni C; Marigo M
Drug Alcohol Depend; 1981 Nov; 8(3):229-34. PubMed ID: 6459917
[TBL] [Abstract][Full Text] [Related]
18. Testosterone and dihydrotestosterone, but not estradiol, selectively maintain pituitary and serum follicle-stimulating hormone in gonadotropin-releasing hormone antagonist treated male rats.
Arslan M; Weinbauer GF; Khan SA; Nieschlag E
Neuroendocrinology; 1989 Apr; 49(4):395-401. PubMed ID: 2497399
[TBL] [Abstract][Full Text] [Related]
19. Levels of luteinizing hormone, follicle-stimulating hormone, testosterone and dihydrotestosterone in the circulation of sexually maturing intact male rats and after orchidectomy and experimental bilateral cryptorchidism.
Gupta D; Rager K; Zarzycki J; Eichner M
J Endocrinol; 1975 Aug; 66(2):183-93. PubMed ID: 240900
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
